Tuesday, March 3, 2015

Reduce Drug Prices by Solving Pharmaceutical R&D Crisis

A new NCPA study concludes that Congress must act to reduce the regulatory burden on pharmaceutical research and development.

Read more at NCPA's Health Policy Blog.

No comments: